Scientific advisory board Member
Scientific advisory board
"r FSSI/COCOBIND, INC"
Dr. Paul Lammers, an entrepreneur in the therapeutic oligonucleotide field, is former Chief Executive Officer of Mirna Therapeutics. Previously he served as President of Repros Therapeutics Inc., a biopharmaceutical company, after having served for 6 years as the Chief Medical Officer for EMD Serono, inc., the biopharmaceutical division of Merck KGaA. Having worked actively in senior roles across the Pharma and Biotech industries for the past 25 years, Dr. Lammers has gained therapeutic experiences in women’s and men’s health, neurodegenerative diseases, metabolic disorders, orphan drug diseases and oncology. Dr. Lammers received a M.Sc. and M.D. from the Catholic University (Radboud University) in Nijmegen, The Netherlands.
therapeutics, metabolic disorders, orphan drug diseases and oncology